Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?

J Card Surg. 2017 Mar;32(3):190-192. doi: 10.1111/jocs.13109. Epub 2017 Feb 21.

Abstract

We describe a case of reversible thrombotic mitral valve stenosis following a valve-in-ring transcatheter mitral valve replacement. Life-long oral anticoagulation in patients who underwent transcatheter mitral valve replacement might be beneficial.

Keywords: bioprosthetic valve thrombosis; transcatheter mitral valve replacement.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage*
  • Aspirin / administration & dosage
  • Bioprosthesis
  • Cardiac Catheterization / methods*
  • Clopidogrel
  • Female
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation / methods*
  • Humans
  • Mitral Valve
  • Mitral Valve Stenosis / drug therapy*
  • Postoperative Complications / drug therapy*
  • Thrombosis / drug therapy*
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives
  • Treatment Outcome
  • Warfarin / administration & dosage

Substances

  • Anticoagulants
  • Warfarin
  • Clopidogrel
  • Ticlopidine
  • Aspirin